Skip to content
MedsAcross

Medicine

Potassium chloride 750 mg extended-release capsule

Available on requestPrescription onlyUS FDAGeneric name

Potassium chloride 750 mg extended-release capsule is a generic prescription medicine for oral use, made by 15 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F) Dispense in a tight, child-resistant…

Key facts

Active ingredient (INN)
Potassium chloride
Brand
Sold under the generic name
Strength
750 mg
Dosage form
Extended-release capsule
Route
Oral
Packs
100 capsules, 500 capsules, 1000 capsules and 34 more
Manufacturers
Granules IndiaIndiaZydus LifesciencesIndiaSun Pharmaceutical IndustriesIndiaBluePoint LaboratoriesAmneal Pharmaceuticals of New YorkPD-Rx PharmaceuticalsA-S Medication SolutionsAmerican Health PackagingNorthStar RxRemedyrepack
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F) Dispense in a tight, child-resistant container as defined in the USP.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A12BA01 Potassium chloride
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
22 February 2013
Identifiers
RxCUI 312504, 315183DailyMed set ID f1791d4f-029a-487f-aee1-fc5be246d0bc, 51586c47-1aff-4ce6-8030-89f9eb1bc9ac, 52d91d76-8c7f-40f1-9f5c-e05962cabedd +15NDC 0615-8442, 68382-854, 43547-553 +14Application ANDA214686, ANDA208445, ANDA209026 +4

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 capsule, extended release in 1 bottle62207-915-43Granules IndiaIndia1 January 2023
500 capsule, extended release in 1 bottle62207-915-47Granules IndiaIndia1 January 2023
1000 capsule, extended release in 1 bottle62207-915-49Granules IndiaIndia1 January 2023
90 capsule, extended release in 1 bottle62207-915-57Granules IndiaIndia1 January 2023
100 capsule, extended release in 1 bottle70010-148-01Granules IndiaIndia1 March 2021
500 capsule, extended release in 1 bottle70010-148-05Granules IndiaIndia1 March 2021
100 capsule, extended release in 1 bottle63304-090-01Sun Pharmaceutical IndustriesIndia2 January 2020
500 capsule, extended release in 1 bottle63304-090-05Sun Pharmaceutical IndustriesIndia2 January 2020
100 capsule, extended release in 1 bottle68382-854-01Zydus LifesciencesIndia30 June 2019
500 capsule, extended release in 1 bottle68382-854-05Zydus LifesciencesIndia30 June 2019
1000 capsule, extended release in 1 bottle68382-854-10Zydus LifesciencesIndia30 June 2019
10 blister pack in 1 carton / 10 capsule, extended release in 1 blister pack68382-854-77Zydus LifesciencesIndia30 June 2019
100 capsule, extended release in 1 bottle53746-542-01Amneal Pharmaceuticals of New York22 February 2013
500 capsule, extended release in 1 bottle53746-542-05Amneal Pharmaceuticals of New York22 February 2013
1000 capsule, extended release in 1 bottle53746-542-10Amneal Pharmaceuticals of New York22 February 2013
100 capsule, extended release in 1 bottle43547-553-10Solco Healthcare30 April 2019
500 capsule, extended release in 1 bottle43547-553-50Solco Healthcare30 April 2019
100 capsule, extended release in 1 bottle68001-396-00BluePoint Laboratories3 July 2019
500 capsule, extended release in 1 bottle68001-396-03BluePoint Laboratories3 July 2019
100 capsule, extended release in 1 bottle68001-619-00BluePoint Laboratories10 July 2024
500 capsule, extended release in 1 bottle68001-619-03BluePoint Laboratories10 July 2024
100 capsule, extended release in 1 bottle, plastic72789-057-01PD-Rx Pharmaceuticals25 February 2020
30 capsule, extended release in 1 bottle, plastic72789-057-30PD-Rx Pharmaceuticals28 July 2023
500 capsule, extended release in 1 bottle, plastic72789-057-82PD-Rx Pharmaceuticals3 October 2022
30 capsule, extended release in 1 bottle50090-7469-0A-S Medication Solutions5 December 2024
90 capsule, extended release in 1 bottle50090-7469-9A-S Medication Solutions5 December 2024
100 blister pack in 1 carton / 1 capsule, extended release in 1 blister pack60687-653-01American Health Packaging20 October 2022
30 blister pack in 1 carton / 1 capsule, extended release in 1 blister pack60687-653-21American Health Packaging14 December 2023
500 capsule, extended release in 1 bottle42291-679-50AvKARE5 March 2013
30 blister pack in 1 box, unit-dose / 1 capsule, extended release in 1 blister pack50268-671-13AvPAK28 January 2016
100 blister pack in 1 carton / 1 capsule, extended release in 1 blister pack0904-7543-61Major Pharmaceuticals18 September 2025
100 capsule, extended release in 1 bottle16714-824-01Northstar Rx16 July 2018
500 capsule, extended release in 1 bottle16714-824-02Northstar Rx16 July 2018
30 capsule, extended release in 1 blister pack70518-4050-0Remedyrepack11 April 2024
100 pouch in 1 box / 1 capsule, extended release in 1 pouch70518-4050-1Remedyrepack15 June 2024
15 capsule, extended release in 1 blister pack0615-8442-05Vangard Labs7 October 2022
30 capsule, extended release in 1 blister pack0615-8442-39Vangard Labs7 October 2022

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 25 April 1975Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Potassium chloride

Clinical summary

Potassium chloride is an osmotic laxative indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. MedsAcross supplies Potassium chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Potassium chloride

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Potassium chloride 750 mg extended-release capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.